Just as it is about to complete the painful 3-year-old integration of its CooperVision (CVI) subsidiary with Ocular Sciences, bought in January 2005, Cooper Companies has announced that CVI will move into the parent company's head office and that there will be some major management changes.
Gregory Fryling, president of CVI, will be leaving his post to pursue other opportunities. His responsibilities will be taken over by Robert Weiss, currently executive vice president and chief operating officer of Cooper Companies. He will have direct responsibilities for the global business of CVI as well as Cooper Surgical.
Steven Neil, currently vice president and chief financial officer of Cooper Companies, is being promoted as executive vice president, with expanded responsibilities for finance and for the integration of CVI's financial and information technology functions into those of the group. Neil will report to Weiss, and Weiss will report to Thomas Bender, chief executive of Cooper Companies. However, Bender has expressed his desire to step down from his role at the end of 2007, although he expects to maintain some kind of continuing role in the company thereafter.